Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer

Published:2017-12-14 Issue:2 Volume:9 Page:1957-1968
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Jue¹²³,Yuan Jing-Ping³,Wang Qun³,Shao Li-Hua³,Liu Shao-Ping³,Firestone Raymond A.⁴,Hong Ya-Ping⁴,Li Ji-Guo⁴,Xin Yan-Chao⁵,Li Yan¹³

Affiliation:

1. Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China

2. Department of Gynecologic Oncology, Hubei Maternal and Child Hospital, Wuhan 430071, P.R.China

3. Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center, Wuhan 430071, P.R. China

4. Nanjing Meihua Pharmaceuticals Ltd., Nanjing 210009, P.R. China

5. Princeton Globalsynthesis LLC, Bristol, PA 19007, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-based hybrid nanostructures for enhanced tumor targeting and hyperthermia therapy;Colloids and Surfaces B: Biointerfaces;2021-09

2. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections;TAM Receptors in Health and Disease;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP